Iranian
Biomedical Journal
Volume 30, Issue 4 (9-2026)
IBJ 2026, 30(4): 254-261 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Aminipour M, Lotfi M, Harzandi N, Babapour E, Mousavi Nasab S D, Ghaderi M. Rescue a Reassortant Human-Bovine Rotavirus and a Recombinant NSP3-EGFP Rotavirus Serotype G1. IBJ 2026; 30 (4) :254-261
URL: http://ibj.pasteur.ac.ir/article-1-5638-en.html
URL: http://ibj.pasteur.ac.ir/article-1-5638-en.html
Mona Aminipour 
, Mohsen Lotfi , Naser Harzandi , Ebrahim Babapour , Seyed Dawood Mousavi Nasab , Mostafa Ghaderi *
, Mohsen Lotfi , Naser Harzandi , Ebrahim Babapour , Seyed Dawood Mousavi Nasab , Mostafa Ghaderi *
Abstract:
Background: Human group A rotaviruses (RVs), with an 11-segmented double-stranded RNA genome, are a cause of viral gastroenteritis in infants and young children. Despite the availability of effective live-attenuated vaccines, RV infection is still a global health challenge. Hence, a reverse genetics system enabling the manipulation of RV segments, such as genome reassortment, is essential for developing new RV vaccines. Herein, a reverse genetics system was used to rescue a reassortant human-bovine RV, incorporating the VP7 gene segment from the human RV strain Wa (serotype G1) and a recombinant RV.
Methods: To rescue a reassortant human-bovine RV, we used a reverse genetics system in which 13 plasmid constructs were co-transfected into BHK-T7 cells. In this method, 10 plasmids were derived from bovine RV, one encoded the human RV VP7 segment of serotype G1, and two expressed the capping enzyme subunits of vaccinia virus. We also created a recombinant RV featuring enhanced green fluorescent protein (EGFP) by replacing the bovine NSP3 plasmid with an NSP3-EGFP construct, where EGFP expression was regulated by an internal ribosomal entry site.
Results: Our results showed successful rescue of the reassortant human-bovine RV and the recombinant strain, with the NSP3-EGFP construct facilitating EGFP translation across multiple RV passages. Replacing the NSP3 gene segment of bovine RV with the release of a recombinant RV enabled EGFP expression in several RV passages.
Conclusion: Our study establishes the feasibility of using a reverse genetics system to generate a live-attenuated RV vaccine candidate, potentially enhancing future control efforts against RV infections.
Methods: To rescue a reassortant human-bovine RV, we used a reverse genetics system in which 13 plasmid constructs were co-transfected into BHK-T7 cells. In this method, 10 plasmids were derived from bovine RV, one encoded the human RV VP7 segment of serotype G1, and two expressed the capping enzyme subunits of vaccinia virus. We also created a recombinant RV featuring enhanced green fluorescent protein (EGFP) by replacing the bovine NSP3 plasmid with an NSP3-EGFP construct, where EGFP expression was regulated by an internal ribosomal entry site.
Results: Our results showed successful rescue of the reassortant human-bovine RV and the recombinant strain, with the NSP3-EGFP construct facilitating EGFP translation across multiple RV passages. Replacing the NSP3 gene segment of bovine RV with the release of a recombinant RV enabled EGFP expression in several RV passages.
Conclusion: Our study establishes the feasibility of using a reverse genetics system to generate a live-attenuated RV vaccine candidate, potentially enhancing future control efforts against RV infections.
Type of Study: Full Length/Original Article |
Subject:
Molecular Immunology & Vaccines
References
1. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003;9(5):565-72. [DOI:10.3201/eid0905.020562]
2. Kanai Y, Kobayashi T. Rotavirus reverse genetics systems: Development and application. Virus Res. 2021;295:198296. [DOI:10.1016/j.virusres.2021.198296]
3. Afchangi A, Jalilvand S, Arashkia A, Latifi T, Farahmand M, Shirazi MM, et al. Co-administration of rotavirus nanospheres VP6 and NSP4 proteins enhanced the anti-NSP4 humoral responses in immunized mice. Microb Pathog. 2022:163:105405. [DOI:10.1016/j.micpath.2022.105405]
4. Kanai Y, Kotaki T, Sakai S, Ishisaka T, Matsuo K, Yoshida Y, et al. Rapid production of recombinant rotaviruses by overexpression of NSP2 and NSP5 genes with modified nucleotide sequences. J Virol. 2024; 98(12):e00996-24. [DOI:10.1128/jvi.00996-24]
5. Fukuda S, Kugita M, Kumamoto K, Akari Y, Higashimoto Y, Nagao S, et al. Generation of recombinant authentic live attenuated human rotavirus vaccine strain RIX4414 (Rotarix®) from cloned cDNAs using reverse genetics. Viruses. 2024;16(8):1198. [DOI:10.3390/v16081198]
6. Wei J, Radcliffe S, Pirrone A, Lu M, Li Y, Cassaday J, et al. A novel rotavirus reverse genetics platform supports flexible insertion of exogenous genes and enables rapid development of a high-throughput neutralization assay. Viruses. 2023;15(10):2034. [DOI:10.3390/v15102034]
7. Yuzhakov A, Yuzhakova K, Kulikova N, Kisteneva L, Cherepushkin S, Smetanina S, et al. Prevalence and genetic diversity of group A rotavirus genotypes in Moscow (2019-2020). Pathogens. 2021;10(6):674. [DOI:10.3390/pathogens10060674]
8. Chen Y, Chen J, Li T, Fan M, Li J, Wang J, et al. Research progress and applications of the rotavirus reverse genetics system. Animals. 2026;16(4):608. [DOI:10.3390/ani16040608]
9. Komoto S, Fukuda S, Murata T, Taniguchi K. Reverse genetics system for human rotaviruses. Microbiol Immunol. 2020;64(6):401-6. [DOI:10.1111/1348-0421.12795]
10. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol. 2005;15(1):29-56. [DOI:10.1002/rmv.448]
11. Kanai Y, Komoto S, Kawagishi T, Nouda R, Nagasawa N, Onishi M, et al. Entirely plasmid-based reverse genetics system for rotaviruses. Proc Natl Acad Sci U S A. 2017;114(9):2349-54. [DOI:10.1073/pnas.1618424114]
12. Kawagishi T, Sanchez-Tacuba L, Feng N, Greenberg HB. Reverse genetics of murine rotavirus: A comparative analysis of the wild-type and cell-culture-adapted murine rotavirus VP4 in replication and virulence in neonatal mice. Viruses. 2024;16(5):767. [DOI:10.3390/v16050767]
13. Mousavi Nasab SD, Sabahi F, Makvandi M, Samiee SM, Nadji SA, Ravanshad M. Epidemiology of rotavirus-norovirus co-infection and determination of norovirus genogrouping among children with acute gastroenteritis in Tehran, Iran. Iran Biomed J. 2016;20(5):280-6.
14. Feng N, Sen A, Wolf M, Vo P, Hoshino Y, Greenberg HB. Roles of VP4 and NSP1 in determining the distinctive replication capacities of simian rotavirus RRV and bovine rotavirus UK in the mouse biliary tract. J Virol. 2010;85(6):2686-94. [DOI:10.1128/JVI.02408-10]
15. Shams S, Mousavi Nasab SD, Heydari H, Tafaroji J, Ahmadi N, Afzali ES. Detection and characterization of rotavirus G and P types from children with acute gastroenteritis in Qom, central Iran. Gastroenterol Hepatol Bed Bench. 2020;13(Suppl1):S128-33.
16. Ciarlet M, Estes MK, Barone C, Ramig RF, Conner ME. Analysis of host range restriction determinants in the rabbit model: Comparison of homologous and heterologous rotavirus infections. J Virol. 1998;72(3):2341-51. [DOI:10.1128/JVI.72.3.2341-2351.1998]
17. Hoshino Y, Saif LJ, Kang SY, Sereno MM, Chen WK, Kapikian AZ. Identification of group A rotavirus genes associated with virulence of a porcine rotavirus and host range restriction of a human rotavirus in the gnotobiotic piglet model. Virology. 1995;209(1):274-80. [DOI:10.1006/viro.1995.1255]
18. Sánchez-Tacuba L, Kawagishi T, Feng N, Jiang B, Ding S, Greenberg HB. The role of the VP4 attachment protein in rotavirus host range restriction in an in vivo suckling mouse model. J Virol. 2022;96(15):e00550-22. [DOI:10.1128/jvi.00550-22]
19. Wahyuni RM, Utsumi T, Dinana Z, Yamani LN, Wuwuti JIS, Fitriana E, et al. Prevalence and distribution of rotavirus genotypes among children with acute gastroenteritis in areas other than Java Island, Indonesia, 2016-2018. Front Microbiol. 2021;12:672837. [DOI:10.3389/fmicb.2021.672837]
20. Kulkarni PS, Desai S, Tewari T, Kawade A, Goyal N, Garg BS, et al. A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.Vaccine. 2017;35(45):6228-37. [DOI:10.1016/j.vaccine.2017.09.014]
21. Uprety T, Wang D, Li F. Recent advances in rotavirus reverse genetics and its utilization in basic research and vaccine development. Arch Virol. 2021;166(9):2369-86. [DOI:10.1007/s00705-021-05142-7]
22. Bergman H, Henschke N, Hungerford D, Pitan F, Ndwandwe D, Cunliffe N, et al. Vaccines for preventing rotavirus diarrhoea: Vaccines in use. Cochrane Database Syst Rev. 2021;11(11):CD008521 [DOI:10.1002/14651858.CD008521.pub6]
23. Velasquez DE, Parashar U, Jiang B. Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: Causes and contributing factors. Expert Rev Vaccines. 2018;17(2):145-61. [DOI:10.1080/14760584.2018.1418665]
24. Komoto S, Sasaki J, Taniguchi K. Reverse genetics system for introduction of site-specific mutations into the double-stranded RNA genome of infectious rotavirus. Proc Natl Acad Sci U S A. 2006;103(12):4646-51. [DOI:10.1073/pnas.0509385103]
25. Falkenhagen A, Patzina-Mehling C, Rückner A, Vahlenkamp TW, Johne R. Generation of simian rotavirus reassortants with diverse VP4 genes using reverse genetics. J Gen Virol. 2019;100(12):1595-1604. [DOI:10.1099/jgv.0.001322]
26. Falkenhagen A, Patzina-Mehling C, Gadicherla AK, Strydom A, O'Neill HG, Johne R. Generation of simian rotavirus reassortants with VP4-and VP7-encoding genome segments from human strains circulating in Africa using reverse genetics. Viruses. 2020;12(2):201. [DOI:10.3390/v12020201]
27. Komoto S, Wakuda M, Ide T, Niimi G, Maeno Y, Higo-Moriguchi K, et al. Modification of the trypsin cleavage site of rotavirus VP4 to a furin-sensitive form does not enhance replication efficiency. J Gen Virol. 2011;92(12):2914-21. [DOI:10.1099/vir.0.033886-0]
28. Mingo R, Zhang S, Long CP, LaConte LEW, McDonald SM. Genetic determinants restricting the reassortment of heterologous NSP2 genes into the simian rotavirus SA11 genome. Sci Rep. 2017;7(1):9301. [DOI:10.1038/s41598-017-08068-w]
29. Fukuda S, Hatazawa R, Kawamura Y, Yoshikawa T, Murata T, Taniguchi T, et al. Rapid generation of rotavirus single-gene reassortants by means of eleven plasmid-only based reverse genetics. J Gen Virol. 2020;101(8):806-15. [DOI:10.1099/jgv.0.001443]
30. Ghaderi M, Sabahi F, Sadeghi-Zadeh M, Khanlari Z, Jamaati A, Mousavi-Nasab SD, et al. Construction of an eGFP expression plasmid under control of T7 promoter and IRES sequence for assay of T7 RNA polymerase activity in mammalian cell lines.Iran J Cancer Prev. 2014;7(3):137-41.
31. Qin SK, Li K-H, Liu B-J, Cao C, Yu D-B, Jiang Z-G, et al. Efficient and robust reverse genetics system for bovine rotavirus generation and its application for antiviral screening. Virol Sin. 2024;39(6):917-28. [DOI:10.1016/j.virs.2024.09.010]
32. Arnold M.M, Brownback CS, Taraporewala ZF, Patton JT. Rotavirus variant replicates efficiently although encoding an aberrant NSP3 that fails to induce nuclear localization of poly (A)-binding protein. J Gen Virol. 2012;93(7):1483-94. [DOI:10.1099/vir.0.041830-0]
33. Patton JT, Taraporewala Z, Chen D, Chizhikov V, Jones M, Elhelu A, et al. Effect of intragenic rearrangement and changes in the 3′ consensus sequence on NSP1 expression and rotavirus replication. J Virol. 2001;75(5):2076-86. [DOI:10.1128/JVI.75.5.2076-2086.2001]
34. Zhu Y, Sánchez-Tacuba L, Hou G, Kawagishi T, Feng N, Greenberg HB, et al. A recombinant murine-like rotavirus with Nano-Luciferase expression reveals tissue tropism, replication dynamics, and virus transmission. Front Immunol. 2022:13:911024. [DOI:10.3389/fimmu.2022.911024]
35. Papa G, Burrone OR. Rotavirus reverse genetics: A tool for understanding virus biology. Virus Res. 2021:305:198576. [DOI:10.1016/j.virusres.2021.198576]
36. Hasan A, Kabir H, Miyaoka Y, Yamaguchi M, Takehara K. G and P genotype profiles of rotavirus a field strains circulating in a vaccinated bovine farm as parameters for assessing biosecurity level. J Vet Med Sci. 2022;84(7):929-37. [DOI:10.1292/jvms.22-0026]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
IBJ is a member of Committee on Publication Ethics (COPE)
and follows its guidelines |
The articles of this journal are licensed under
a Creative Commons Attribution-NonDerivatives 4.0 International License. .png) |
 IBJ is owned and published by Pasteur Institute of Iran |